Prime Medicine announces positive Phase 1/2 data for PM359, leadership changes, and strategic pipeline prioritization, focusing on liver diseases. Prime Medicine, Inc. announced initial positive data ...
As part of this agreement, Western Flyer Xpress' power units will use Prime's refrigerated trailers, while both companies will remain independent. Prime Inc. recently entered a partnership with ...
Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.
Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.46 per share a year ago. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results